Advertisement

Topics

Syndax and AZ perform solid tumor combo trial

14:40 EST 14 Feb 2018 | Elsevier Business Intelligence

Syndax Pharmaceuticals Inc. agreed to pair its monoclonal antibody SNDX6352 with AstraZeneca PLC’s anti-PD-L1 antibody durv...

Original Article: Syndax and AZ perform solid tumor combo trial

NEXT ARTICLE

More From BioPortfolio on "Syndax and AZ perform solid tumor combo trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...